deltatrials
Recruiting OBSERVATIONAL NCT00582881

Characteristics and Disease Progression of Mixed Connective Tissue Disease and Systemic Lupus Erythematosus

Immune Response to Small Nuclear Ribonucleoprotein Autoantigens

Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Conditions Mixed Connective Tissue Disease (MCTD) Systemic Lupus Erythematosus (SLE)
Updated 18 times since 2017 Last updated: Mar 5, 2025 Started: Oct 31, 2007 Primary completion: Sep 30, 2027 Completion: Sep 30, 2029
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00582881, this observational or N/A phase trial focuses on Mixed Connective Tissue Disease (MCTD) and Systemic Lupus Erythematosus (SLE) and remains actively recruiting participants. Sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), it has been updated 18 times since 2007, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Aug 2017 · 7 months · monthly snapshot~Aug 2017 – ~Apr 2018 · 8 months · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Nov 2018 · 5 months · monthly snapshot~Nov 2018 – ~Jul 2019 · 8 months · monthly snapshot~Jul 2019 – ~Jul 2020 · 12 months · monthly snapshot~Jul 2020 – ~Nov 2020 · 4 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Jun 2021 · 5 months · monthly snapshot~Jun 2021 – ~Dec 2021 · 6 months · monthly snapshot~Dec 2021 – ~May 2022 · 5 months · monthly snapshot~May 2022 – ~Apr 2023 · 11 months · monthly snapshot~Apr 2023 – ~Apr 2024 · 12 months · monthly snapshot~Apr 2024 – ~Jul 2024 · 3 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Apr 2025 · 7 months · monthly snapshot~Apr 2025 – present · 17 months · monthly snapshot

Change History

18 versions recorded

  1. Apr 2025 — Present [monthly]

    Recruiting

  2. Sep 2024 — Apr 2025 [monthly]

    Recruiting

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting

  4. Apr 2024 — Jul 2024 [monthly]

    Recruiting

  5. Apr 2023 — Apr 2024 [monthly]

    Recruiting

▶ Show 13 earlier versions

  1. May 2022 — Apr 2023 [monthly]

    Recruiting

  2. Dec 2021 — May 2022 [monthly]

    Recruiting

  3. Jun 2021 — Dec 2021 [monthly]

    Recruiting

  4. Jan 2021 — Jun 2021 [monthly]

    Recruiting

  5. Nov 2020 — Jan 2021 [monthly]

    Recruiting

  6. Jul 2020 — Nov 2020 [monthly]

    Recruiting

  7. Jul 2019 — Jul 2020 [monthly]

    Recruiting

  8. Nov 2018 — Jul 2019 [monthly]

    Recruiting

  9. Jun 2018 — Nov 2018 [monthly]

    Recruiting

  10. May 2018 — Jun 2018 [monthly]

    Recruiting

  11. Apr 2018 — May 2018 [monthly]

    Recruiting

    Phase: NA → None

  12. Aug 2017 — Apr 2018 [monthly]

    Recruiting NA

  13. Jan 2017 — Aug 2017 [monthly]

    Recruiting NA

    First recorded

Oct 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
  • University of Miami
Data source: University of Miami

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations